ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 259 filers reported holding ACCELERON PHARMA INC in Q1 2021. The put-call ratio across all filers is 1.21 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,851,000 | -17.0% | 13,650 | -21.7% | 0.00% | -20.0% |
| Q4 2020 | $2,231,000 | -54.2% | 17,435 | -59.7% | 0.01% | -54.5% |
| Q3 2020 | $4,869,000 | +3.1% | 43,270 | -12.7% | 0.01% | -8.3% |
| Q2 2020 | $4,721,000 | -17.2% | 49,551 | -21.9% | 0.01% | -29.4% |
| Q1 2020 | $5,699,000 | +2066.9% | 63,415 | +1023.2% | 0.02% | +1600.0% |
| Q1 2019 | $263,000 | -93.6% | 5,646 | -94.0% | 0.00% | -90.9% |
| Q4 2018 | $4,088,000 | -62.2% | 93,870 | -50.4% | 0.01% | -56.0% |
| Q3 2018 | $10,828,000 | +4337.7% | 189,205 | +3663.8% | 0.02% | +2400.0% |
| Q2 2018 | $244,000 | -95.4% | 5,027 | -96.3% | 0.00% | -93.3% |
| Q1 2018 | $5,274,000 | – | 134,893 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |